Noncolorectal, Nonneuroendocrine Liver Metastases: Diagnosis and Current Therapies PDF
Preview Noncolorectal, Nonneuroendocrine Liver Metastases: Diagnosis and Current Therapies
Noncolorectal, Nonneuroendocrine Liver Metastases Diagnosis and Current Therapies Isidoro Di Carlo Editor Foreword by Masatoshi Makuuchi 123 Noncolorectal, Nonneuroendocrine Liver Metastases Isidoro Di Carlo Editor Noncolorectal, Nonneuroendocrine Liver Metastases Diagnosis and Current Therapies Foreword by Masatoshi Makuuchi Editor Isidoro Di Carlo, MD, PhD, FACS Department of Surgical Sciences Organ Transplantation and Advanced Technologies University of Catania Cannizzaro Hospital Catania Italy ISBN 978-3-319-09292-8 ISBN 978-3-319-09293-5 (eBook) DOI 10.1007/978-3-319-09293-5 Springer Cham Heidelberg New York Dordrecht London Library of Congress Control Number: 2014956271 © Springer International Publishing Switzerland 2015 T his work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifi cally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher's location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. T he use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specifi c statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. While the advice and information in this book are believed to be true and accurate at the date of publication, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) Foreword I n the last three decades, hepatic surgery for liver metastases from colorectal or neuroendocrine cancer has undergone radical development and gained widespread acceptance. Knowledge of the segmental and subsegmental liver anatomy and hepatic regeneration has expanded markedly, ability to evaluate the functional reserve has improved, and new surgical instruments and procedures have been intro- duced. As a consequence, surgery for liver metastases from colorectal or neuroen- docrine cancer is now considered safe and is performed on a daily basis. I n our own experience, it proved possible to remove at fi rst attempt 97 colorectal liver metastases and 185 neuroendocrine liver metastases. Repeat resection was per- formed whenever recurrence was detected, including six times in one patient with colorectal liver metastases and up to four times in patients with neuroendocrine liver metastases. At repeat resection, a total of 268 further tumors were removed. The results of surgery have also improved dramatically every year. I n contrast, however, noncolorectal, nonneuroendocrine liver metastases require further study and refi nement of treatment owing to their rarity compared with colorectal and neuroendocrine metastases. The treatment varies depending on the primary malignancy and disease stage, and liver resection is indicated in only a limited number of cases. It is currently scarcely possible to say that established guidelines exist. It was against this background that Professor Isidoro Di Carlo accepted the chal- lenge of addressing the issues surrounding the resection of noncolorectal, nonneu- roendocrine liver metastases in this book. The co-authors, who are all top world surgeons, consider all possible primary malignancies in individual chapters. O ne doctor will have very few opportunities to experience the resection of non- colorectal, nonneuroendocrine liver metastases. Therefore, this book, which covers all state-of-the-art surgeries of liver metastases from primary malignancies in 15 organs, is very important. I would like to recommend that all surgeons and hepatolo- gists specializing in hepatic surgery read it thoroughly and refer to it each time they encounter noncolorectal or nonneuroendocrine liver metastasis. I believe this book will shed much light on the still unclear fi eld of liver metastasis. Tokyo, Japan Masatoshi Makuuchi , MD v Pref ace Unlike in the case of metastases from colorectal and neuroendocrine tumors, the advantages of hepatic resection for metastases from non-colorectal non- neuroendocrine (NCRNNE) cancer have not been well proven to date. Nevertheless, interest in these metastases is continuously increasing in the medical community, as evidenced by the signifi cant increase in publications over the past 30 years. This trend is in part due to refi nement of diagnostic methods and progress in oncology, but it is especially attributable to the safety with which liver surgery, whether open, laparoscopic or robotic, can now be performed. It has already been demonstrated that highly selected patients can achieve long- term survival after resection of liver metastases from NCRNNE cancer. However, it is diffi cult to compare and draw conclusions from published series owing to differ- ences in respect of the primary malignancy. Indeed, the full spectrum of this disease remains to be explored. This was the motivation for editing the present text: to provide a reliable point of reference for all specialists involved in the care of this disease. In order to achieve this goal, I asked the most renowned hepatic surgeons in the world to describe com- prehensively their personal experiences and to summarize the currently available literature. Since liver metastases from some primary tumors are very rare, with lim- ited experience reported by hepatic surgeons, I also engaged other specialists to achieve a complete coverage of the disease. In this way, all NCRNNE liver metas- tases have been described and for each one the reader is supplied with current answers concerning diagnosis and treatment. I would like to express my gratitude to all the authors of each chapter. Without their skills and experience this book would not have been possible. I will conclude in expressing my personal deep gratitude, and that of all coauthors, for the great privilege of having Professor Masatoshi Makuuchi’s presenting this volume. Catania, Italy Isidoro Di Carlo, MD, PhD, FACS October 2014 vii Contents 1 Liver Metastases from Adrenocortical Carcinomas. . . . . . . . . . . . . . 1 Adriana Toro and Isidoro Di Carlo 2 Liver Metastases from Breast Cancer . . . . . . . . . . . . . . . . . . . . . . . . . 15 Arash Nickkholgh and Arianeb Mehrabi 3 Liver Metastases from Kidney Cancer . . . . . . . . . . . . . . . . . . . . . . . . 33 Enrico Pinotti, Francesca Ratti, Federica Cipriani, and Luca Aldrighetti 4 Liver Metastases from Larynx Cancer . . . . . . . . . . . . . . . . . . . . . . . . 49 Satyan B. Sreenath, Rupali N. Shah, and Adam M. Zanation 5 Liver Metastases from Lung Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . 63 Giorgio Ercolani, Flavia Neri, Matteo Ravaioli, Matteo Cescon, and Antonio Daniele Pinna 6 Liver Metastases from Melanoma Cancer. . . . . . . . . . . . . . . . . . . . . . 69 Charbel Sandroussi 7 Liver Metastases from Ovarian and Uterus Cancer. . . . . . . . . . . . . . 79 Anya Adair and Stephen J. Wigmore 8 Liver Metastases from Pancreatic Adenocarcinoma . . . . . . . . . . . . . 95 Jin He, David Cosgrove, Joseph M. Herman, and Timothy M. Pawlik 9 Liver Metastasis from Salivary Gland Tumors. . . . . . . . . . . . . . . . . . 111 Parul J. Shukla and Chetan Merchant 10 Hepatic Metastases from Sarcomas . . . . . . . . . . . . . . . . . . . . . . . . . . . 117 Adriana Toro and Isidoro Di Carlo 11 Liver Metastases from Stomach Cancer . . . . . . . . . . . . . . . . . . . . . . . 131 Akio Saiura 12 Management of Liver Metastases from Testicular Cancer . . . . . . . . 147 Hishaam Ismael and Thomas A. Aloia ix
The list of books you might like
